X-67545306-T-TTGC
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM4_SupportingPP5BS2
The NM_000044.6(AR):c.170_172dup(p.Leu57dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000245 in 1,143,668 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., 5 hem., cov: 19)
Exomes 𝑓: 0.000017 ( 0 hom. 4 hem. )
Consequence
AR
NM_000044.6 inframe_insertion
NM_000044.6 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.29
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM4
?
Nonframeshift variant in NON repetitive region in NM_000044.6. Strenght limited to Supporting due to length of the change: 1aa.
PP5
?
Variant X-67545306-T-TTGC is Pathogenic according to our data. Variant chrX-67545306-T-TTGC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 958035.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=2}.
BS2
?
High Hemizygotes in GnomAd at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AR | NM_000044.6 | c.170_172dup | p.Leu57dup | inframe_insertion | 1/8 | ENST00000374690.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AR | ENST00000374690.9 | c.170_172dup | p.Leu57dup | inframe_insertion | 1/8 | 1 | NM_000044.6 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000121 AC: 10AN: 82407Hom.: 0 Cov.: 19 AF XY: 0.000292 AC XY: 5AN XY: 17137
GnomAD3 genomes
?
AF:
AC:
10
AN:
82407
Hom.:
Cov.:
19
AF XY:
AC XY:
5
AN XY:
17137
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000189 AC: 3AN: 158966Hom.: 0 AF XY: 0.0000347 AC XY: 2AN XY: 57580
GnomAD3 exomes
AF:
AC:
3
AN:
158966
Hom.:
AF XY:
AC XY:
2
AN XY:
57580
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000170 AC: 18AN: 1061261Hom.: 0 Cov.: 30 AF XY: 0.0000116 AC XY: 4AN XY: 343641
GnomAD4 exome
AF:
AC:
18
AN:
1061261
Hom.:
Cov.:
30
AF XY:
AC XY:
4
AN XY:
343641
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000121 AC: 10AN: 82407Hom.: 0 Cov.: 19 AF XY: 0.000292 AC XY: 5AN XY: 17137
GnomAD4 genome
?
AF:
AC:
10
AN:
82407
Hom.:
Cov.:
19
AF XY:
AC XY:
5
AN XY:
17137
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Androgen resistance syndrome;C1839259:Kennedy disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 11, 2024 | This variant, c.170_172dup, results in the insertion of 1 amino acid(s) of the AR protein (p.Leu57dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs752055010, gnomAD 0.007%), including at least one homozygous and/or hemizygous individual. This variant has been observed in individual(s) with AR-related conditions (PMID: 25500996, 28261839; Invitae). In at least one individual the variant was observed to be de novo. This variant is also known as p.Leu57dup and p.57_58insLeu. ClinVar contains an entry for this variant (Variation ID: 958035). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. - |
Malignant tumor of prostate Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 11, 2023 | The c.170_172dupTGC (p.L57dup) alteration, located in coding exon 1 of the AR gene. The alteration consists of an in-frame duplication of 3 nucleotides from position 170 to 172. This results in the duplication of a leucine residue at codon 57._x000D_ _x000D_ for AR-related androgen insensitivity syndrome; however, it is unlikely to be causative of AR-related spinal and bulbar muscular atrophy. Based on data from gnomAD, the c.170_172dupTGC allele has an overall frequency of 0.003% (6/174505) total alleles studied, with 2 hemizygotes observed. The highest observed frequency was 0.007% (1/14938) of African alleles. This variant has been reported in multiple individuals with features consistent with AR-related androgen insensitivity syndrome (Ferlin, 2006; Su, 2017; Liu, 2020), including a de novo occurrence (He, 2021). A functional study has demonstrated reduced cellular expression and transactivation activity in a luciferase assay (70% of wildtype) for p.L57dup (Tadokoro-Cuccaro, 2014). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at